NTRK1 and thyroid gland carcinoma: The central role in the oncogenesis of thyroid carcinoma is the constitutive activation of the MAPK signaling pathway through mutations or the fusion of its essential proteins such as receptor tyrosine kinases (RTKs, which includes RET, ALK, VEGFR, and TRK), RAS, RAF, MEK, and ERK.